NCT04704622View on ClinicalTrials.gov

Comparison Between Dexmeditomidine, Midazolam and Ketamine as a Sedative to Help Cannula Insertion in Pediatric Patient

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Cannula Site Pain
Interventions
DRUG

Ketamine

ketamine intranasal injection,2 mg/kg, once, 30 min preoperative

DRUG

Midazolam

midazolam intranasal injection,0.2mg/kg, once, 30 min preoperative

DRUG

Dexmedetomidine

dexmedetomidine intranasal injection,1 μg/kg, once, 30 min preoperative

Trial Locations (1)

11591

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04704622 - Comparison Between Dexmeditomidine, Midazolam and Ketamine as a Sedative to Help Cannula Insertion in Pediatric Patient | Biotech Hunter | Biotech Hunter